|
Sintilimab (approved) Clinical Trials
2 actively recruiting trials
▲ +1 trial since June 2026
Pipeline
Phase 2: 2
Top Sponsors
- West China Hospital1
- Second Affiliated Hospital, School of Medicine, Zhejiang University1
Indications
- Cancer2
- Extensive Disease Small Cell Lung Cancer1
- Liver Disease1
- Extensive Stage Lung Small Cell Cancer1
- Extensive Stage Small Cell Lung Cancer (ES-SCLC)1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.